As proof of concept, we focused on polymorphisms within regulatory elements bound by two TFs, ER-α and AR, that are key nuclear receptors in common human cancers characterized by a genetic component to their etiology, breast and prostate cancers [16, 17]. This evidence concerns the gene AR and prostate carcinoma.